Indomethacin is generally intended for the shortest effective course, ideally days to a few weeks, because its side effects can appear faster and hit harder than those of most other anti-inflammatory drugs. Some conditions do call for longer treatment, but even a one-week course in otherwise healthy people can cause measurable stomach damage. The drug’s reputation as one of the most potent prescription anti-inflammatories cuts both ways, and the timeline of risk is tighter than many patients expect.
Why Short-Term Use Is the Default
Indomethacin works by blocking the enzymes that produce prostaglandins, the same chemicals that drive inflammation, pain, and fever. But prostaglandins also do protective work throughout the body: they help maintain the stomach lining, keep blood flowing through the kidneys, and regulate blood pressure. Shutting them down aggressively is useful when you need rapid pain control for something like a gout flare or pericarditis, but it also means the drug’s side effects are an extension of its mechanism, not an accident. Indomethacin may also have stronger blood-vessel-narrowing activity and unique effects on nerve signaling pathways compared with other drugs in the same class, which could explain both its effectiveness for certain headache disorders and its tendency to produce more side effects.1PubMed. The Pharmacology of Indomethacin
Most prescribing guidelines reflect this trade-off. For acute gout, a typical course runs about a week. For chronic conditions like ankylosing spondylitis or certain headache syndromes, doctors sometimes prescribe it for months, but almost always with regular monitoring of blood work and kidney function. The question is not just “how long is safe” in the abstract but how quickly the specific risks accumulate for you, given your age, kidney health, heart history, and what other medications you take.
How Quickly Gastrointestinal Damage Develops
The stomach is the organ that takes the fastest hit. In a study of healthy volunteers with no Helicobacter pylori infection who took a standard dose of indomethacin three times daily for just seven days, gastric lesions were found in seven out of ten people, and actual stomach ulcers developed in three of them.2Journal of Clinical Biochemistry and Nutrition. Prevention of Indomethacin-Induced Gastric Mucosal Injury in Helicobacter pylori-Negative Healthy Volunteers: A Comparison Study Rebamipide vs Famotidine That is a striking rate for one week of treatment in people who had no pre-existing stomach problems. These were endoscopic findings, meaning the subjects might not have felt symptoms yet, but the damage was real and detectable.
This does not mean everyone who takes a five-day gout course will develop ulcers. Individual susceptibility varies, and many people complete short courses without noticeable stomach trouble. But the study illustrates why doctors are wary of extended indomethacin use: the gastrointestinal lining can erode quickly, and the erosion is often silent until something bleeds or perforates. Older adults, people with a history of ulcers, and those taking corticosteroids or blood thinners at the same time face even steeper odds.
Protecting the Stomach During Longer Courses
When indomethacin must continue for more than a few days, doctors often co-prescribe a stomach-protective drug. A large Cochrane review of strategies for preventing NSAID-related ulcers found that several approaches work, though not equally well. Misoprostol at higher doses significantly reduced both gastric and duodenal ulcers seen on endoscopy, but it frequently caused diarrhea. Proton pump inhibitors and double-dose H2 receptor antagonists were also effective at reducing both types of ulcers and were better tolerated than misoprostol.3PubMed Central. Prevention of NSAID-induced gastroduodenal ulcers Standard-dose H2 blockers only reduced duodenal ulcers, not gastric ones, making them a less complete safeguard.
If your doctor puts you on indomethacin for several weeks or longer, ask whether you should also be taking a proton pump inhibitor. The combination does not eliminate the stomach risk, but it meaningfully lowers it. This is especially relevant if you have any additional risk factors for ulcers.
Kidney Function and Indomethacin
The kidneys rely on prostaglandins to keep adequate blood flow, especially when the body is under stress. Indomethacin suppresses those prostaglandins, and in people whose kidney blood flow is already compromised, this can tip the balance toward acute kidney failure. Case reports have documented this happening in patients who were dehydrated or had pre-existing circulatory problems; one patient needed temporary dialysis before kidney function began recovering within five days of stopping the drug.4PubMed. Acute intrinsic renal failure induced by indomethacin: role of prostaglandin synthetase inhibition Another case in a patient with chronic kidney disease showed a similar pattern: kidney function deteriorated on indomethacin and recovered once it was withdrawn.5JAMA. Reversible Acute Renal Failure Induced by Indomethacin
These are dramatic examples, but even at less extreme levels, indomethacin measurably changes how the kidneys work. A study of long-term indomethacin treatment found a sustained drop of about 41 percent in urinary prostaglandin E2 levels and a mild decrease in a standard measure of kidney filtration. The drug also blunted the kidneys’ ability to respond to furosemide, a common diuretic, and reduced their concentrating ability.6PubMed. Effects of long-term treatment with indomethacin on renal function For most healthy people on a short course, these changes resolve after stopping the medication. For someone with borderline kidney function, diabetes, heart failure, or who is taking other drugs that stress the kidneys, the margin is thinner and the timeline before damage occurs is shorter.
Cardiovascular Risk
All NSAIDs carry warnings about heart risk, and indomethacin is no exception. A population-level study found that current NSAID use was associated with about a 30 percent higher risk of a first hospital admission for heart failure after controlling for other major risk factors. Duration and dose did not clearly change the risk in the general population in that analysis. But in people who already had a clinical diagnosis of heart failure, current NSAID use was associated with a dramatically higher risk of hospitalization compared with people who had no heart failure history and were not using NSAIDs.7BMJ Journals. Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population
The practical message is straightforward. If you have heart failure or significant cardiovascular disease, indomethacin is a poor choice at any duration. If you are otherwise healthy, the cardiovascular risk from a brief course is relatively small, but it is not zero, and it adds to whatever baseline risk you carry. The cardiovascular concern is another reason prolonged courses demand careful justification.
Central Nervous System Side Effects
One underappreciated aspect of indomethacin safety is how often it causes neurological symptoms. An extended clinical study reported that headache, dizziness, lightheadedness, and “disturbed sensorium” (a broad term covering confusion, foggy thinking, and disorientation) occurred at a combined rate of roughly 47 percent. In about one in five patients, these effects were severe enough to require stopping the drug entirely.8JAMA. An Extended Study of Indomethacin: I. Clinical Pharmacology This is a remarkably high discontinuation rate driven by a single category of side effects.
These symptoms tend to emerge in the first days of treatment and sometimes improve if the dose is reduced. But for people who are already prone to balance problems or cognitive issues, such as older adults, the neurological effects can be dangerous in their own right because they raise the risk of falls. If you start indomethacin and develop persistent headaches, dizziness, or mental fogginess, those are not just nuisances to power through. They are a signal that the drug may not be a good fit for you, regardless of how much time is left on your prescribed course.
Liver Enzymes and Monitoring
Indomethacin can cause elevations in liver enzymes, which typically show up on routine blood work.9QJM: An International Journal of Medicine. Effect of indomethacin (Non steroidal anti-inflammatory drug) on intestinal permeability and liver functions Clinically significant liver injury from indomethacin is uncommon, but the possibility is part of why doctors check blood work periodically during longer courses. If your liver enzymes climb above normal on a routine panel, that can prompt a switch to a different anti-inflammatory before real damage develops. This monitoring step is one of the invisible safety nets that makes longer use possible when it is medically necessary, and it is also why taking indomethacin without medical follow-up for weeks on end is risky.
Older Adults Face Higher Stakes
Indomethacin appears on the Beers Criteria, a widely used list of medications considered potentially inappropriate for older adults. A study of elderly patients in Western Australia found that indomethacin was associated with a 40 percent increase in the odds of unplanned hospitalization, which was the highest among the anti-rheumatic drugs examined. Naproxen also raised the risk, but indomethacin’s effect was larger.10Springer Link / Drugs & Aging. Impact of specific Beers Criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: a case-time-control study in Western Australia
The reasons stack up: older kidneys are less resilient, the stomach lining thins with age, cardiovascular disease is more prevalent, and the neurological side effects (dizziness, confusion) are both more common and more consequential when a fall can mean a broken hip. If you are over 65 and a doctor prescribes indomethacin, the expectation is usually the shortest possible course. When an older adult needs ongoing anti-inflammatory treatment, other options with gentler risk profiles are typically preferred.
Topical Formulations as a Lower-Risk Alternative
One way to get some of indomethacin’s benefits while reducing systemic exposure is to use a topical formulation. Topical NSAIDs deliver drug concentrations in local tissues that can be several times higher than what oral dosing achieves in those same tissues, while peak blood levels remain below about 10 percent of what you would see after swallowing a pill. Bioavailability through the skin generally runs between 1 and 7 percent of an equivalent oral dose.11PubMed Central. Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022)
That pharmacokinetic profile substantially reduces the risk of stomach injury, kidney effects, and cardiovascular complications. Topical indomethacin is not appropriate for every condition the oral form treats, since it works best for localized musculoskeletal pain near the skin surface, but when the problem is a sore joint or tendon rather than a systemic inflammatory condition, the topical route lets you treat for a longer period with far less systemic risk. If your doctor is hesitant about extending an oral course, asking about a topical alternative is a reasonable conversation to have.
Before Surgery
If you are taking indomethacin and have a scheduled surgery, you will likely be asked to stop it beforehand because of its effects on platelet function and bleeding risk. A review of preoperative medication management for spine surgery recommended stopping indomethacin at least two days before the procedure, which puts it in a middle tier among NSAIDs: shorter than naproxen or meloxicam (four days) but longer than ibuprofen (one day).12PubMed Central. When to stop anticoagulation, anti-platelet aggregates, and non-steroidal anti-inflammatories (NSAIDs) prior to spine surgery The timeline reflects how long the drug’s effects on bleeding persist after the last dose. If you are on a longer course for a chronic condition and surgery comes up, plan the discontinuation with both your surgeon and prescribing doctor rather than simply stopping on your own.
Indomethacin in Pregnancy and Newborns
Indomethacin has a second life in obstetrics and neonatology, where it is used to slow preterm labor and to close a common heart defect in premature infants called patent ductus arteriosus. These applications involve very short courses, typically a few doses, and the safety concerns are quite different from those in adult long-term use.
When given to mothers for preterm labor, prenatal indomethacin exposure has been linked to higher rates of serious complications in the newborn. In one study comparing exposed and unexposed premature infants, those whose mothers received indomethacin had higher rates of necrotizing enterocolitis (about 29 percent versus 8 percent) and significant intracranial hemorrhage (about 28 percent versus 9 percent).13N Engl J Med. Neonatal complications after the administration of indomethacin for preterm labor These findings helped shape the current cautious approach, where indomethacin for tocolysis is reserved for narrow clinical windows and limited to 48 hours or less, and is generally avoided after 32 weeks of gestation because of the risk of premature closure of the fetal ductus arteriosus.
For closing the patent ductus arteriosus in newborns after birth, dose matters. A comparison of high-dose and standard-dose regimens found that higher doses closed the duct more often (about 79 percent versus 65 percent) but at the cost of significantly more gastrointestinal hemorrhage, lung disease, and eye disease in the high-dose group.14PubMed. High Dose Indomethacin for Patent Ductus Arteriosus Closure Increases Neonatal Morbidity A trial of low-dose intravenous indomethacin found similar closure rates and comparable safety profiles between the low-dose and standard-dose groups, suggesting that lower doses may achieve the goal with fewer complications.15Scientific Reports. The efficiency and safety of low-dose intravenous indomethacin for closure of patent ductus arteriosus in preterm neonate: a randomized controlled trial These neonatal applications underline a principle that applies to adult use as well: the lowest effective dose for the shortest effective period yields the best safety trade-off.
Genetic Variation in How You Process the Drug
Not everyone clears indomethacin from their body at the same speed. The drug is metabolized primarily by a liver enzyme called CYP2C9, and genetic variants of this enzyme are relatively common. A pharmacokinetic study in pregnant women found that individuals carrying certain CYP2C9 variants had nearly double the clearance rate of indomethacin compared with those carrying the standard version of the gene, though the sample was small and the differences did not reach statistical significance.16PubMed Central. Effect of CYP2C9 polymorphisms on the pharmacokinetics of indomethacin during pregnancy Faster clearance could mean you need higher or more frequent doses to get the same effect, while slower clearance could mean the drug lingers longer and side effects accumulate more readily.
Pharmacogenomic testing is not yet standard practice before prescribing indomethacin, but this research helps explain why two people on the same dose can have such different experiences. If you seem unusually sensitive to indomethacin, experiencing strong side effects at low doses or finding that it wears off faster than expected, genetic variation in drug metabolism is one possible explanation worth discussing with your doctor. It does not change the general safety guidance, but it adds a layer of individual variability that broad guidelines cannot capture.
When Longer Courses Are Medically Justified
Certain conditions genuinely require prolonged indomethacin therapy. Chronic paroxysmal hemicrania and hemicrania continua are headache disorders that respond specifically and sometimes exclusively to indomethacin; this response is so distinctive that it is used as a diagnostic criterion. Patients with these conditions may take indomethacin for months or years, and the calculus shifts from “avoid long-term use” to “manage the risks of long-term use because there is no alternative.” The same applies in some cases of ankylosing spondylitis or other inflammatory arthropathies where indomethacin provides relief that other NSAIDs do not match.
In these scenarios, the monitoring regimen typically includes periodic blood tests to check kidney function, liver enzymes, and a complete blood count. Stomach-protective medication is often co-prescribed from the start. The dose is kept as low as effective, and doctors periodically attempt dose reductions to see if the condition can be controlled with less drug. It is a managed risk rather than an open-ended prescription.
The honest answer to the title question is that there is no single safe number of days. A five-day course for gout is well within accepted practice for most healthy adults. Two weeks starts to warrant closer attention, especially to the stomach and kidneys. Months of continuous use demand active monitoring and usually gastroprotection. And the risk calculation shifts dramatically depending on your age, kidney function, cardiovascular status, and what other medications you are on. The thread running through all the evidence is that indomethacin is a powerful tool with a narrow margin, and the duration you can take it safely depends less on a calendar date and more on how closely you and your doctor are watching for trouble.